...
首页> 外文期刊>Case Reports in Oncology >Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma
【24h】

Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma

机译:转移性肾细胞癌的同时放射栓塞和免疫检查点抑制。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

This case represents the challenge and creativity necessary when treating patients with metastatic renal cell carcinoma who have been exposed to multiple lines of therapy. At present, treatment with immune checkpoint inhibition has stabilized and improved the metastatic disease of this patient with the exception of hepatic lesions. This isolated progression within the liver led the employment of radioembolization, which successfully treated those metastases. This is the first documented case of metastatic renal cell carcinoma controlled with concurrent use of immune checkpoint inhibition and radioembolization for both extrahepatic and hepatic metastases, respectively. This case can be construed as a potential example of the abscopal effect and may provide the basis for understanding this type of response in select patients.
机译:这种情况代表了在接受过多种疗法治疗的转移性肾细胞癌患者治疗中所必需的挑战和创造力。目前,用免疫检查点抑制治疗已稳定并改善了该患者的肝转移病(转移病)。肝脏内部这种孤立的进展导致了放射栓塞的成功应用,成功地治疗了这些转移灶。这是第一个有记录的转移性肾细胞癌病例,同时同时使用免疫检查点抑制和放射栓塞治疗肝外和肝转移。这种情况可以被解释为抽象影响的潜在例子,并且可以为理解特定患者中这种类型的反应提供基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号